Using the TCL1-ovalbumin (OVA)-expressing mouse model to generate T cells specific for OVA antigen expressed by leukemic cells, this study further demonstrated that Tregs derived from CLL-bearing mice could suppress proliferation of CLL-specific CD8+ T cells (69). The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.